AAA Rupture Risk Assessment in COVID-19 Pandemic
Biomechanical Rupture Risk Assessment in Management of Patients With Abdominal Aortic Aneurysm in COVID-19 Pandemic
1 other identifier
observational
102
1 country
1
Brief Summary
The acute phase of the COVID-19 pandemic requires a redefinition of healthcare system to increase the number of available intensive care units for COVID-19 patients. This leads to the postponing of elective surgeries including the treatment of abdominal aortic aneurysm (AAA). The probabilistic rupture risk index (PRRI) recently showed its advantage over the diameter criterion in AAA rupture risk assessment. Its major improvement is in increased specificity and yet has the same sensitivity as the maximal diameter criterion. The objective of this study was to test the clinical applicability of the PRRI diagnostic method in a quasi-prospective observational patient cohort study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2021
CompletedFirst Submitted
Initial submission to the registry
January 15, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedJanuary 25, 2022
January 1, 2022
1.8 years
January 15, 2022
January 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Test the clinical applicability of the BRRA method
Identify the number of number of false positive and false negative cases assessed by BRRA method according to clinical data and compare these data to control group where the decision making process was based only on maximal diameter of AAA
21 months
Secondary Outcomes (1)
Reduction of time required for AAA assessment
21 months
Study Arms (2)
BRRA group
Rupture risk of asymptomatic AAAs in this group was estimated using Biomechanical rupture rist assessment (BRRA). BRRA considers an AAA as a pressure vessel and estimates its risk of rupture by comparing its wall stress to wall strength
Maximal diameter group
Rupture risk of asymptomatic AAAs in this group was estimated by a classical approach based on a maximal diameter.
Interventions
3D computational model is created from CT angiographic images available during standard AAA diagnostic process. Vascular wall stress is assessed based on the 3D model using Finite element method to identify highly stressed parts of AAA and results are compared to populational wall strength information (gathered from previous large histological study), thus rupture risk (stress/strength ratio) of each particular AAA is estimated. Other relevant factors such as gender, blood pressure, presence of intraluminal thrombus etc. are used during the calculation as well.
Eligibility Criteria
Patients diagnosed with asymptomatic AAA during the COVID-19 pandemic period. During this period an elective surgeries had to be posponed and there was a need for auxiliary diagnostic method able to identify AAAs with high risk of rupture.
You may qualify if:
- presence of asymptomatic abdominal aortic aneurysm (AAA)
- regular CT angiography scans available
You may not qualify if:
- rupture of AAA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Masaryk Universitylead
- VSB - Technical University of Ostravacollaborator
Study Sites (1)
St. Anne´s University Hospital in Brno
Brno, 65691, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Robert Staffa, M.D., Ph.D.
Masaryk University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Invastigator
Study Record Dates
First Submitted
January 15, 2022
First Posted
January 19, 2022
Study Start
March 12, 2020
Primary Completion
December 17, 2021
Study Completion
March 1, 2022
Last Updated
January 25, 2022
Record last verified: 2022-01